155 related articles for article (PubMed ID: 22161860)
1. Overexpression of Evi-1 oncoprotein represses TGF-β signaling in colorectal cancer.
Deng X; Cao Y; Liu Y; Li F; Sambandam K; Rajaraman S; Perkins AS; Fields AP; Hellmich MR; Townsend CM; Thompson EA; Ko TC
Mol Carcinog; 2013 Apr; 52(4):255-264. PubMed ID: 22161860
[TBL] [Abstract][Full Text] [Related]
2. The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling.
Izutsu K; Kurokawa M; Imai Y; Maki K; Mitani K; Hirai H
Blood; 2001 May; 97(9):2815-22. PubMed ID: 11313276
[TBL] [Abstract][Full Text] [Related]
3. The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
Kurokawa M; Mitani K; Imai Y; Ogawa S; Yazaki Y; Hirai H
Blood; 1998 Dec; 92(11):4003-12. PubMed ID: 9834202
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic mechanisms of Evi-1 protein.
Hirai H; Izutsu K; Kurokawa M; Mitani K
Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S35-40. PubMed ID: 11587364
[TBL] [Abstract][Full Text] [Related]
5. Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1.
Alliston T; Ko TC; Cao Y; Liang YY; Feng XH; Chang C; Derynck R
J Biol Chem; 2005 Jun; 280(25):24227-37. PubMed ID: 15849193
[TBL] [Abstract][Full Text] [Related]
6. Evi-1 as a critical regulator of leukemic cells.
Goyama S; Kurokawa M
Int J Hematol; 2010 Jun; 91(5):753-7. PubMed ID: 20532840
[TBL] [Abstract][Full Text] [Related]
7. The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3.
Kurokawa M; Mitani K; Irie K; Matsuyama T; Takahashi T; Chiba S; Yazaki Y; Matsumoto K; Hirai H
Nature; 1998 Jul; 394(6688):92-6. PubMed ID: 9665135
[TBL] [Abstract][Full Text] [Related]
8. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
[TBL] [Abstract][Full Text] [Related]
9. Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies.
Goyama S; Kurokawa M
Cancer Sci; 2009 Jun; 100(6):990-5. PubMed ID: 19385966
[TBL] [Abstract][Full Text] [Related]
10. Role of TGF-β in metastatic colon cancer: it is finally time for targeted therapy.
Villalba M; Evans SR; Vidal-Vanaclocha F; Calvo A
Cell Tissue Res; 2017 Oct; 370(1):29-39. PubMed ID: 28560691
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of leukemogenesis by AML1/EVI-1.
Mitani K
Oncogene; 2004 May; 23(24):4263-9. PubMed ID: 15156182
[TBL] [Abstract][Full Text] [Related]
12. Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter.
Bartholomew C; Ihle JN
Mol Cell Biol; 1991 Apr; 11(4):1820-8. PubMed ID: 1848663
[TBL] [Abstract][Full Text] [Related]
13. EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinoma.
Yasui K; Konishi C; Gen Y; Endo M; Dohi O; Tomie A; Kitaichi T; Yamada N; Iwai N; Nishikawa T; Yamaguchi K; Moriguchi M; Sumida Y; Mitsuyoshi H; Tanaka S; Arii S; Itoh Y
Cancer Sci; 2015 Jul; 106(7):929-37. PubMed ID: 25959919
[TBL] [Abstract][Full Text] [Related]
14. NR2F2 inhibits Smad7 expression and promotes TGF-β-dependent epithelial-mesenchymal transition of CRC via transactivation of miR-21.
Wang H; Nie L; Wu L; Liu Q; Guo X
Biochem Biophys Res Commun; 2017 Mar; 485(1):181-188. PubMed ID: 28192117
[TBL] [Abstract][Full Text] [Related]
15. Masking epistasis between MYC and TGF-β pathways in antiangiogenesis-mediated colon cancer suppression.
Dews M; Tan GS; Hultine S; Raman P; Choi J; Duperret EK; Lawler J; Bass A; Thomas-Tikhonenko A
J Natl Cancer Inst; 2014 Apr; 106(4):dju043. PubMed ID: 24627270
[TBL] [Abstract][Full Text] [Related]
16. Evi-1 Influence on Clinical Progress of Colorectal Cancer Patients.
Zhu Y; Zhang J; Ye Z; Peng P; Lan X; Xie L; Qin M; Huang J
Ann Clin Lab Sci; 2020 May; 50(3):354-360. PubMed ID: 32581025
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
18. The human promyelocytic leukemia zinc finger gene is regulated by the Evi-1 oncoprotein and a novel guanine-rich site binding protein.
Takahashi S; Licht JD
Leukemia; 2002 Sep; 16(9):1755-62. PubMed ID: 12200691
[TBL] [Abstract][Full Text] [Related]
19. Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells.
Arai S; Yoshimi A; Shimabe M; Ichikawa M; Nakagawa M; Imai Y; Goyama S; Kurokawa M
Blood; 2011 Jun; 117(23):6304-14. PubMed ID: 21190993
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor Evi-1.
Hirai H
Int J Biochem Cell Biol; 1999 Dec; 31(12):1367-71. PubMed ID: 10641791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
